| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO & Secretary | COO, CFO & Secretary | CFO and Secretary +6 more
1 company
Christopher K. Scott last filed a Form 4 in February 2022, as CFO & Secretary at IRMD. Christopher K. Scott's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Christopher K. Scott a middling insider score of 60/100, based on 5 past trades. Over a 12-month horizon, all 5 of those trades were profitable, with an average 12-month return of +26.1%.
At the last filing, the largest reported position was 13,710 shares of IRMD. The IRMD filings lean toward selling, a net 150,536 shares.
Christopher K. Scott has 24 Form 4 filings on record from January 2016 to February 2022, all as CFO & Secretary at Iradimed (IRMD), 2016–2022.
The 59 reported transactions were 17 option exercises, 17 tax withholdings, 10 option or other derivative awards and 8 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $4.9M.
The largest open-market sale was 96,250 shares of IRMD at an average $26.05 on August 8, 2018, about $2.5M.
Shares as reported in the last Form 4 for each company; the most recent is from February 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2022 | IRMD Iradimed Corp | CFO & Secretary | Sell | 19,286 | $50.06 | $965,424.37 | -58.4% | -34.5% | -25.8% | |
| Nov 23, 2021 | IRMD Iradimed Corp | COO, CFO & Secretary | Sale+OE | 26,715 | $40.98 | $1,094,692.54 | -48.3% | +20.7% | -25.4% | |
| Nov 17, 2021 | IRMD Iradimed Corp | COO, CFO & Secretary | Sale+OE | 8,285 | $40.03 | $331,619.68 | -22.5% | +27.6% | -26.5% | |
| Aug 8, 2018 | IRMD Iradimed Corp | CFO | Sale+OE | 96,250 | $26.05 | $2,507,647.63 | -94.0% | - | - |